Histochemical techniques provide the most accurate histological method for localizing substances, substrates and enzymes. In the past, histochemistry has suffered from the drawback that it has been essentially non-quantitative. However, with recent emphasis on quantitative histochemistry and cytochemistry, the gap between what is called "slide" histochemistry and "test-tube" histochemistry is being closed. For information about these quantitative methods the reader is referred to reviews on cytochemistry by Lowry (1964) and Davison and Gregson (1965) , on microdissection technique by Hyden (1962) , on cytoarchitectonics by Pope (1960) , on histochemical enzyme kinetics by Glenner (1965) , and on cytophotometry by Pollister and Ornstein (1959) and Eranko and Raisanen (1961) . In this paper, however, it is proposed neither to discuss quantitation in histochemistry nor the various pitfalls and caveats in histochemical and cytochemical techniques; my purpose is to illustrate the applicability and use of some "slide" histochemical methods for localization in the nervous system. These methods are of great value for some research problems and are proving to be useful aids in some aspects of diagnosis.
A variety of histochemical techniques may be used for the localization of lipids in the nervous system (for refs. see reviews by Adams, 1962a and papers by Holczinger, 1959 Wolman, 1961 ; Adams, Bayliss and Ibrahim, 1963) . With these techniques the following major groups of lipids may be identified and localized: free cholesterol, triglyceride/ cholesterol esters, free fatty acids, phospholipids, phosphoglycerides (lecithins and cephalins), sphingomyelin, cerebroside, sulphatide and plasmalogen phospholipids. Recent new techniques for choline-containing lipids (Bottcher and Boelsma-van Houte, 1964) and ganglioside (Shear and Pearse, 1963) have been introduced but have not yet been fully evaluated in practice. These histochemical methods for lipids depend upon precise principles which are often the same as those used in quantitive biochemical studies. However, the histochemist is faced with the problem that his reactions must be performed on tissue lipids in situ, whereas the biochemist can partition, fractionate, elute or otherwise purify his lipid samples before analyzing them.
Histochemical lipid methods have been used to study the fate of the myelin lipids in both experimental and human demyelinating conditions <for refs. see reviews by Adams, 1962a,b; . These studies confirm biochemical observations on demyelination which show that myelin lipids are chemically degraded to cholesterol esters (Johnson, McNabb and Rossiter, 1950; Cumings, 1953 Cumings, , 1955 Rodnight 1956 Rodnight -1957 Plum and Hansen, 1960; Gerst! et al., 1961; Davison and Wajda, 1962) . However, this chemical degradation of myelin is preceded by physico-chemical changes in the sheath, possibly involving rupture of lipid-protein bonds and release of active lytic enzymes (see reviews by Rossiter, 1961 and Adams 1962a ).
These lipid methods may also be applied to the problem of identifying or staining the storage lipids in a number of cerebral and visceral lipidoses, such as amaurotic familial idiocy, metachromatic leucodystrophy, Niemann-Pick's disease and Gaucher's disease. It is pointed out, however, that the "histochemical picture" of cerebral lipid storage may be altered by the simultaneous occurrance of demyelination and formation of esterified cholesterol.
Histochemical enzyme methods are now being used fairly extensively, both to detect specific enzyme changes and as general indicators of cell function and viability.
Acetylcholinesterase methods (see review by Koelle, 1962) have been used to map various tracts in the central and peripheral nervous systems (Shute and Lewis, 1963) , to study parasympathetic ganglia and fibres, and as diagnostic aids in diseases of the neuro-muscular junction (Coers and Woolf, 1959) and intoxication by cholinesterase in-. hibitors (Petty, 1955) . As an example, the acetycholinesterase technique shows in achalasia of the cardia that the myenteric ganglion cells disappear from the segment of the oesophagus immediately above the cardia, but some ganglion cells are preserved within the cardia itself. Likewise, in Hirschsprung's disease, ganglion cells can be shown to be absent from the affected spastic segment of colon, but a remarkable hyperplasia of preganglionic fibres is seen in the affected ganglion area (Adams, Marples and Trounce, 1960) .
The tetrazolium methods for dehydrogenases and nucleotide reductases ("diaphorases") are also widely used in neurohistochemistry. These techniques depend on diverting electron-transfer from specific dehydrogenases or reductases (through NAD or NADP and flavoprotein) towards a suitable tetrazolium salt; this diversion is enhanced by poisoning the cytochrome system with cyanide. After accepting electrons, the tetrazolium salt is reduced to a brightly coloured insoluble formazan, The limitations of these methods have been extensively investigated and discussed (see reviews by Pearse, 1960 and Glenner, 1965; Novikoff, 1959 and Farber and Morrison, 1964) ; the use of an intermediary electron acceptor has been advocated for the precise intracellular localization of some specific dehydrogenases.
The tetrazolium methods have been used in investigations on oxidative activity in the normal nervous system (Thomas and Pearse, 1961) , experimental brain necrosis (Rubinstein, Klatzo and Miguel, 1962; Smith and Rubinstein, 1962) , astrocytic activation (Schiffer and Vesco, 1963) , Alzheimer's disease (Friede and Magee, 1962) , leucodystrophies (Nelson et al., 1962 (Nelson et al., , 1963 , ischaemia (Spector, 1963) , various cerebrovas-cular diseases (Friede, Magee and Mack, 1961; Friede, 1962; Adams, 1965) , axonal reaction and Wallerian degeneration (Friede, 1959 (Friede, , 1964 , muscle disease (Engel, 1965) and tumour pathology (Lehrer, 1962; Chason et al., 1963) . As an example of the use of these tetrazolium methods, we observed that oxidative enzyme activity is increased in the centre of early plaques and at the edge of established plaques of multiple sclerosis (Friede, 1961; : This increased activity was localized to the proliferating oligodendrocytes in or around the lesion.
Similar enzymic activation and oligodendroglia1 proliferation occurs in both the prodromal and demyelinating stages of experimental cyanide encephalopathy ,.but.these neuroglial enzyme changes are distinct from those seen in brain injury or experimental cerebral oedema (Ibrahim, Morgan and Adams, 1965) . The stimulus that produces this oligodendroglial activation in demyelinating conditions still remains an outstanding and enigmatic problem.
Limitations of time and space allow no more than passing reference to electronhistochemical investigations on the ATPases of neuroglial membranes (To rack and Barnett, 1964) and to neurohistochemical studies on other nucleotide phosphatases (Barron and Tuncbay, 1962,) esterases (Peplar and Pearse, 1957) , proteins (see Dixon, 1954; Adams and Tuqan, 1961) , mucopolysaccharides (Young and Abood, 1960; Hess, 1962) , nucleic acids (Einarson and Krogh, 1955) , catecholamines (Eranko, 1956; Falk et al., 1962) and iron (Hallgren and Sourander, 1960) 
